drugset / Trial / NCT05002946
Pharmacokinetics of SP-104
RandomizedCrossoverOpen-labelBasic science
Summary
This open-label, 3-period, 3-treatment, randomized study will characterize the pharmacokinetics and safety and tolerability of SP-104 under fasting and fed conditions as compared to the pharmacokinetics of Naltrexone Hydrochloride Tablets, USP, 50 mg in healthy adult subjects.
Timeline
- Start
- 2022-01-11
- Primary completion
- 2022-04-24
- Completion
- 2022-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | — | Oral |
| Comparator | Naltrexone | Small molecule | 50 mg | Oral |
Indications
No indication recorded.